-
In this issue: Statins and liver function; dosing timing for thyroxine; rivaroxaban for VTE, DVT, and stroke; echinacea and the common cold; and FDA actions.
-
-
A randomized, double-blind, placebo-controlled trial of the efficacy of oral amoxicillin-clavulanate treatment (40 mg amoxicillin + 5.7 mg clavulanate/kg/day divided into 2 daily doses for 7 days) of acute otitis media was conducted among children 6-35 months of age in Finland.
-
In intensive-care units, death attributable to infections caused by multidrug-resistant bacteria, especially Pseudomonas aeruginosa and Acinetobacter baumannii species, is a common occurrence.
-
-
In a prospective, randomized, double-blind, placebo-controlled trial of women taking SRI's, sildenafil treatment resulted in a reduction of sexual side effects.
-
Peyronie's disease is an uncommon penile fibrotic disorder that most commonly affects young and middle-aged men. It is characterized by pain, deformity, or decreased capacity for intromission as a result of penile angulation.
-
In a large study of American adults, all-cause mortality was lowest for those with a body mass index (BMI) of 20.0-24.9 kg/m2.
-
Hepatitis A has been greatly reduced in the United States due to widespread vaccination, and most new cases are now the result of international travel.
-
The FDA has approved the first treatment for pseudobulbar affect (PBA).
